SCHEMBL344074

SCHEMBL344074

CCCCCCCCCCCCC(CCCCCCCCCCCC)(C(=O)O)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.48
GPR84 Q9NQS5 7/20 0.48
PPARG P37231 7/20 0.48
PPARD Q03181 7/20 0.48
PPARA Q07869 7/20 0.48
HDAC11 Q96DB2 5/20 0.48
TSHR P16473 4/20 0.48
PTPN1 P18031 3/20 0.48
ALDH1A1 P00352 2/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
SLC22A8 Q8TCC7 1/20 0.48
MEN1 O00255 1/20 0.48
ESR1 P03372 1/20 0.48
ALOX15 P16050 1/20 0.48
PDE4A P27815 1/20 0.48
KMT2A Q03164 1/20 0.48
PDE3A Q14432 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3213688 1.00 CES2 (0.48) CES2GPR84PPARGPPARDPPARA
SCHEMBL5279943 1.00 CES2 (0.48) CES2GPR84PPARGPPARDPPARA
SCHEMBL338291 1.00 CES2 (0.48) CES2GPR84PPARGPPARDPPARA
SCHEMBL5860239 1.00 CES2 (0.48) CES2GPR84PPARGPPARDPPARA
SCHEMBL11071652 1.00 CES2 (0.48) CES2GPR84PPARGPPARDPPARA
SCHEMBL2231045 1.00 CES2 (0.48) CES2GPR84PPARGPPARDPPARA
SCHEMBL5859421 1.00 CES2 (0.48) CES2GPR84PPARGPPARDPPARA
SCHEMBL9953987 1.00 CES2 (0.48) CES2GPR84PPARGPPARDPPARA
SCHEMBL21269866 1.00 CES2 (0.48) CES2GPR84PPARGPPARDPPARA
SCHEMBL337636 1.00 CES2 (0.48) CES2GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12187923-B2 Michael-addition-hardening synthetic resin for chemical fixing technology FISCHERWERKE GMBH & CO. KG (DE) 2025-01-07 US claimed
US-12180394-B2 Michael-addition-hardening hybrid system for chemical fixing technology FISCHERWERKE GMBH & CO. KG (DE) 2024-12-31 US claimed
US-20230002653-A1 MICHAEL-ADDITION-HARDENING HYBRID SYSTEM FOR CHEMICAL FIXING TECHNOLOGY FISCHERWERKE GMBH & CO. KG (DE) 2023-01-05 US claimed
US-20220411680-A1 MICHAEL-ADDITION-HARDENING SYNTHETIC RESIN FOR CHEMICAL FIXING TECHNOLOGY FISCHERWERKE GMBH & CO. KG (DE) 2022-12-29 US claimed
EP-4069797-A1 MICHAEL REACTION-CURING SYNTHETIC RESIN FOR USE IN CHEMICAL FASTENING TECHNOLOGY fischerwerke GmbH & Co. KG (DE) 2022-10-12 EP claimed
EP-4069792-A1 MICHAEL REACTION-CURING HYBRID SYSTEM FOR USE IN CHEMICAL FASTENING TECHNOLOGY fischerwerke GmbH & Co. KG (DE) 2022-10-12 EP claimed
EP-3662044-B1 DETERGENT ADDITIVE DOW GLOBAL TECHNOLOGIES LLC (US) 2022-08-03 EP claimed
WO-2021110622-A1 MICHAEL REACTION-CURING SYNTHETIC RESIN FOR USE IN CHEMICAL FASTENING TECHNOLOGY FISCHERWERKE GMBH & CO. KG (DE) 2021-06-10 WO claimed
WO-2021110621-A1 MICHAEL REACTION-CURING HYBRID SYSTEM FOR USE IN CHEMICAL FASTENING TECHNOLOGY FISCHERWERKE GMBH & CO. KG (DE) 2021-06-10 WO claimed
EP-3662049-B1 ENCAPSULATION METHOD DOW GLOBAL TECHNOLOGIES LLC (US) 2021-05-05 EP claimed
US-12187923-B2 Michael-addition-hardening synthetic resin for chemical fixing technology FISCHERWERKE GMBH & CO. KG (DE) 2025-01-07 US disclosed
US-12180394-B2 Michael-addition-hardening hybrid system for chemical fixing technology FISCHERWERKE GMBH & CO. KG (DE) 2024-12-31 US disclosed
US-12110529-B2 Methods and systems using ionophores to control contamination in fermentation of gaseous substrates SYNATA BIO, INC. (US) 2024-10-08 US disclosed
US-12037378-B2 Variant CD58 domains and uses thereof NOVARTIS AG (CH) 2024-07-16 US disclosed
US-12037378-B2 Variant CD58 domains and uses thereof NOVARTIS AG (CH) 2024-07-16 US disclosed
US-5395433-A Containing electron donor coloring and electron acceptor compounds which react to induce color formation; printers for computers, facsimile apparatus RICOH COMPANY, LTD. (JP) 1995-03-07 US disclosed
US-5379058-A Recording apparatus using a thermosensitive recording medium RICOH COMPANY, LTD. (JP) 1995-01-03 US disclosed
US-5296439-A Support with reversible thermosensitive coloring recording layer containing electron donor coloring compound, electron acceptor which reacts to induce color formation RICOH COMPANY, LTD. (JP) 1994-03-22 US disclosed
EP-0576015-A1 Method of reversible recording Ricoh Company, Ltd (JP) 1993-12-29 EP disclosed
EP-0492628-A1 Reversible thermosensitive coloring composition, recording medium, recording method and image display apparatus using the recording medium Ricoh Company, Ltd (JP) 1992-07-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12037378-B2 Variant CD58 domains and uses thereof CD2, CD58, CD2BP2 CES2 3823/4885GPR84 1136/4885PPARG 4780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.